Ellie Williams wins 78th Harden Conference Poster Prize

Ellie Williams has won the poster prize for the Biochemical Society's 78th Harden Conference: Protein Kinases in Health and Disease. She presented the recent work she and her colleagues have done investigating a pre-clinical compound (K04284) that may have applications in the rare disease Fibrodisplasia Ossificans Progressiva (FOP). FOP is caused by a single point mutation in the ALK2 kinase leading to uncontrolled bone formation and there is currently no treatment. K04284 is already in Phase 2 clinical trials for the treatment of some cancers and its additional activity against ALK2 provides exciting potential for fast track clinical trials for FOP.